# A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects

> **NCT04804904** · PHASE1 · COMPLETED · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Pharmacokinetic Study

## Interventions

- **DRUG:** TQ-B3101

## Key facts

- **NCT ID:** NCT04804904
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-20
- **Primary completion:** 2021-06-15
- **Final completion:** 2021-07-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04804904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04804904, "A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04804904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*